Business
business
Jon Keegan

Anduril building $1 billion factory to churn out autonomous weapons and vehicles

Autonomous-weapons systems startup Anduril announced plans to build a $1 billion “hyperscale” factory in Columbus, Ohio. Named “Arsenal-1,” the sprawling 5 million-square-foot, airport-adjacent factory complex will be optimized for “the mass production of autonomous systems and weapons,” according to the company’s press release. The company said the factory is expected to create 4,000 jobs.

Anduril, founded by Palmer Luckey in 2017 after selling his Oculus VR startup to Facebook (Meta) in 2014, is a big player in the emerging group of “defense technology” companies currently pitching the US government on ways to bring AI to the battlefield. The startup is backed by Peter Thiel, and is currently valued at $14 billion.

Recently a wave of AI companies have leaned into defense. Palantir has partnered with AI startup Anthropic to include its AI models for national-security applications, and OpenAI and Meta have both started pitching their AI platforms for use in defense.

A group of tech companies including Anduril, Palantir, OpenAI, and SpaceX have partnered up in an effort to compete against legacy defense-industry giants Lockheed Martin, Boeing, and RTX.

Anduril, founded by Palmer Luckey in 2017 after selling his Oculus VR startup to Facebook (Meta) in 2014, is a big player in the emerging group of “defense technology” companies currently pitching the US government on ways to bring AI to the battlefield. The startup is backed by Peter Thiel, and is currently valued at $14 billion.

Recently a wave of AI companies have leaned into defense. Palantir has partnered with AI startup Anthropic to include its AI models for national-security applications, and OpenAI and Meta have both started pitching their AI platforms for use in defense.

A group of tech companies including Anduril, Palantir, OpenAI, and SpaceX have partnered up in an effort to compete against legacy defense-industry giants Lockheed Martin, Boeing, and RTX.

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.